Mediventus Pharmaceuticals Private Limited
About Mediventus Pharmaceuticals Private Limited
Data last updated:
Mediventus Pharmaceuticals Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 08 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85300UP2020PTC128185.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohd Afsheen and Mohd Monish.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1238 Karim Nagar Ansar Block, Meerut, Uttar Pradesh, India – 250002.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.35 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹125 (net margin 0%) and EBITDA of ₹1,776 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
Company details
Contact details
Mediventus Pharmaceuticals Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address1238 Karim Nagar Ansar Block, Meerut, Uttar Pradesh, India – 250002
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Mediventus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mediventus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mediventus Pharmaceuticals Private Limited, buy the company report.
Financials of Mediventus Pharmaceuticals Private Limited
FY 2025 filings availableMediventus Pharmaceuticals Private Limited reported revenue of ₹4.35 Lakh (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 29% fall in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1,776 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹125 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.4% | |||
| Net Profit Margin | 0% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Mediventus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mediventus Pharmaceuticals Private Limited
Mediventus Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Afsheen | Director | 08 Apr 2020 | 6 Years 7 Months | Current |
| Mohd Monish | Director | 08 Apr 2020 | 6 Years 7 Months | Current |
Peer comparison
Mediventus Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Birmshire Pharmaceuticals Private Limited | ₹4.36 Lakh (FY 2024) | -34.0% | New Delhi, Delhi, India | |||
| Aidsoulasia Pharmaceuticals Private Limited | ₹4.36 Lakh (FY 2023) | -9.0% | Noida, Uttar Pradesh, India | |||
| Mediventus Pharmaceuticals Private Limitedthis company | ₹4.35 Lakh (FY 2024) | ₹125 | 0% | -29.0% | Meerut, Uttar Pradesh, India | |
| Moonbio Pharmaceuticals Private Limited | ₹4.34 Lakh (FY 2017) | Dhanbad, Jharkhand, India | ||||
| Byblis Pharmaceuticals Private Limited | ₹4.31 Lakh (FY 2024) | 19.0% | New Delhi, Delhi, India |
To see the full peer comparison of Mediventus Pharmaceuticals Private Limited, buy the company report.
Auditor
Mediventus Pharmaceuticals Private Limited is audited by I ANSARI AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| I ANSARI AND ASSOCIATES | FY 2022 | 427073 |
Shareholding
The shareholding of Mediventus Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mediventus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mediventus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediventus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mediventus Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mediventus Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Mohd Afsheen was appointed as Director on 08 Apr 2020.
Frequently asked questions
Mediventus Pharmaceuticals is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 08 April 2020 (6+ years old) and is registered under CIN U85300UP2020PTC128185.
Mediventus Pharmaceuticals has 2 current directors:
- Mohd Afsheen - Director
- Mohd Monish - Director
The latest financial statements of Mediventus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Mediventus Pharmaceuticals is U85300UP2020PTC128185. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediventus Pharmaceuticals was incorporated on 08 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Mediventus Pharmaceuticals by revenue are Birmshire Pharmaceuticals Private Limited, Aidsoulasia Pharmaceuticals Private Limited, Moonbio Pharmaceuticals Private Limited, Byblis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohd Afsheen was appointed as Director on 08 Apr 2020. Mohd Monish was appointed as Director on 08 Apr 2020.
The registered office of Mediventus Pharmaceuticals is at 1238 Karim Nagar Ansar Block, Meerut, Uttar Pradesh, India – 250002.
Mediventus Pharmaceuticals operates in the non-profit organizations industry, in the social work segment.
Mediventus Pharmaceuticals can be reached at its registered office: 1238 Karim Nagar Ansar Block, Meerut, Uttar Pradesh, India – 250002.
Mediventus Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
